This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Complicating Conditions That Influence Treatment Selection and Dosing

Guideline 15: Selecting Antipsychotics for a Patient With a Complicating Condition

 

Published: January 1, 2004

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

The experts would avoid clozapine, olanzapine, and conventional antipsychotics, especially low and mid-potency agents, in patients who have diabetes, obesity, or dyslipidemia. They would avoid clozapine, ziprasidone, and conventional antipsychotics, especially low- and mid-potency agents, in patients with QTc prolongation or congestive heart failure. They preferred quetiapine or olanzapine for patients with prolactin-related disorders such as galactorrhea or gynecomastia and quetiapine for patients with Parkinson’s disease.’ ‹


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 65

Quick Links: Psychotic Disorders , Schizophrenia and Schizoaffective Disorders

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...

Read More...